Mammen BioProcess Support ApS: Financial statements 2026
CVR: 43983881
Source: annual report 2026, Danish Business Authority
01/04/2025 – 31/03/2026
Mammen BioProcess Support ApS (CVR 43983881) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 1,787,690 and a net result of DKK 362,902 compared with DKK 261,391 the year before. That is an increase of 19.1% compared with the year before. Equity in the 2026 report amounted to DKK 670,757. The solvency ratio was 72.8%.
- Gross Profit
- DKK 1,787,690
- Profit/Loss
- DKK 362,902
- Equity
- DKK 670,757
- Total Assets
- DKK 920,905
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | - | 1.8M | 363K | 671K | 0 |
| 2025 | - | 1.5M | 261K | 308K | 0 |
| 2024 | - | 1.6M | 436K | 476K | 1 |
Official annual report
Find more companies like Mammen BioProcess Support ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorAbout Mammen BioProcess Support ApS
Mammen BioProcess Support ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2023. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for byggeri og anlægsarbejder. The management consists of Max Løjtved Mammen. The company is owned by Max Mammen Holding ApS. The company has 1 employee (2026). In 2026, the company reported a gross profit of DKK 1,787,690 and a net result of DKK 362,902 compared with DKK 261,391 the year before. Equity in the 2026 report amounted to DKK 670,757.
